Results 1 to 10 of about 7,237 (150)

Transcatheter Left Atrial Appendage Closure

Methodist DeBakey Cardiovascular Journal, 2023
Atrial fibrillation is the most common arrhythmia worldwide, placing a large population at risk for potentially disabling ischemic strokes, yet an estimated 50% of eligible patients cannot tolerate or are contraindicated to receive oral anticoagulation ...
Gordon X. Wong, Gagan D. Singh
doaj   +3 more sources

Left Atrial Appendage Closure Devices

Clinical Medicine Insights: Cardiology, 2014
Atrial fibrillation (AF) increases the risk for thromboembolic stroke five-fold. The left atrial appendage (LAA) has been shown to be the main source of thrombus formation in the majority of strokes associated with AF.
Jorge Romero, Irving E. Perez, Andrew Krumerman, Mario J. Garcia, Richard J. Lucariello   +4 more
doaj   +4 more sources

Left Atrial Appendage Closure Under Intracardiac Echocardiographic Guidance: Feasibility and Comparison With Transesophageal Echocardiography

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundTranscatheter left atrial appendage closure is an alternative therapy for stroke prevention in atrial fibrillation patients. These procedures are currently guided with transesophageal echocardiography and fluoroscopy in most centers.
Yae Matsuo, Petr Neuzil, Jan Petru, Milan Chovanec, Marek Janotka, Subbarao Choudry, Jan Skoda, Lucie Sediva, Masahiko Kurabayashi, Vivek Y. Reddy   +9 more
doaj   +3 more sources

Transjugular left atrial appendage closure

REC: Interventional Cardiology (English Ed.)
A 52-year-old woman with atrial fibrillation, thrombocytopenia, and severe gastrointestinal bleeding while on several anticoagulants was referred for left atrial appendage closure.
Juan Gabriel Córdoba-Soriano, Juan Carlos García-López, Jesús Jiménez-Mazuecos   +2 more
doaj   +3 more sources

Update on left atrial appendage closure for neurologists. [PDF]

Eur Stroke J
Abstract A significant proportion of patients with atrial fibrillation (AF) who need thromboembolic protection are not treated with or discontinue oral anticoagulation after its initiation. Undertreatment in clinical practice has not improved sufficiently despite the availability of direct oral anticoagulants, which are associated ...
Haeusler KG, Sposato LA, Grygier M, Potpara T, Nielsen-Kudsk JE, Boersma LVA, Lip GYH, Schnabel RB, Osmancik P, Schmidt B, Döhner W, Kovac J, Camm AJ.   +12 more
europepmc   +4 more sources

Endocardial obliterative left atrial appendage closure by inverted purse-string plicationCentral MessagePerspective [PDF]

JTCVS Techniques
Objective: To describe an endocardial obliterative left atrial appendage closure (LAAC) technique using inverted appendage purse-string plication added to 2-layer orifice closure and to evaluate anatomic and clinical outcomes in minimally invasive and ...
Yoshitsugu Nakamura, MD, PhD, Taisuke Nakayama, MD, PhD, Miho Kuroda, MD, Yuto Yasumoto, MD, Chihiro Shirai, ME   +4 more
doaj   +2 more sources

Left Atrial Appendage Closure: A Current Overview Focused on Technical Aspects and Different Approaches

Reviews in Cardiovascular Medicine, 2022
Several studies in literature have shown that 90% of emboli related to non-valvular atrial fibrillation originate from left atrial appendage. Percutaneous closure or surgical exclusion of left atrial appendage in patients with high bleeding and high ...
Fabrizio Guarracini, Marta Martin, Massimiliano Marini, Stefano Branzoli, Giulia Casagranda, Daniele Muser, Giovanni B. Forleo, Alessio Gasperetti, Massimo Di Marco, Stefano Guarracini, Roberto Bonmassari, Patrizio Mazzone, Antonio M Calafiore, Michele Di Mauro   +13 more
doaj   +1 more source

Percutaneous left atrial appendage closure [PDF]

Vnitřní lékařství, 2020
Stroke is one of the most severe complications of atrial fibrillation. Oral anticoagulation is the first choice therapy in prevention of cardiac embolic events. Particularly in patients with the history of serious bleeding, oral anticoagulation may be contraindicated.
Marek, Hozman, Pavel, Osmančík
openaire   +2 more sources

Two‐Year Outcomes With a Next‐Generation Left Atrial Appendage Device: Final Results of the PINNACLE FLX Trial

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background The PINNACLE FLX (Protection Against Embolism for Non‐valvular AF [Atrial Fibrillation] Patients: Investigational Device Evaluation of the Watchman FLX LAA [Left Atrial Appendage] Closure Technology) trial evaluated the safety and efficacy of ...
Shephal K. Doshi, Saibal Kar, Ashish Sadhu, Rodney Horton, Jose Osorio, Christopher Ellis, James Stone, Manish Shah, Srinivas R. Dukkipati, Stuart Adler, Devi G. Nair, Jamie Kim, Oussama Wazni, Matthew J. Price, David R. Holmes, Robert Shipley, Thomas Christen, Dominic J. Allocco, Vivek Y. Reddy   +18 more
doaj   +1 more source

Transcatheter Left Atrial Appendage Closure: Devices Available, Pitfalls, Advantages, and Future Directions

US Cardiology Review, 2023
Transcatheter left atrial appendage closure has emerged as a non-pharmacological alternative to long-term anticoagulation for stroke prevention in appropriately selected patients with AF.
Chirag Bavishi
doaj   +1 more source